Skip to main content

Global Vascular Access Device Market witnessing 6% CAGR rise due to higher hospital IV procedures by 2030

 


The vascular access device market is experiencing a steady growth rate with a CAGR of ~6% during the forecast period. The primary factor driving the market growth is the increasing incidence of chronic diseases requiring frequent or long-term intravenous therapy. Additionally, demand for minimally invasive procedures, the growing geriatric population, and technological advancements in catheter design and materials are further driving the market growth. However, the rising number of catheter-acquired infections may hinder the market growth. 

A vascular access device (VAD) is a medical apparatus inserted into a patient’s vein to deliver medications, fluids, blood products, or draw blood samples. These devices include central venous catheters, peripheral venous catheters, peripherally inserted central catheters and implanted ports. These devices play a significant role in managing diabetes, cancer, renal diseases or other severe conditions, requiring repeated vascular access without frequent needle pricks.

Download a free sample report now 👉
https://meditechinsights.com/vascular-access-device-market/request-sample/

Chronic disease burden driving demand for vascular access devices

One of the main factors propelling the VAD market is the rising global prevalence of chronic diseases such as cancer, diabetes, and end-stage renal disease. According to an article published by the WHO, there were approximately 43 million deaths in 2021, and three out of every four deaths were due to chronic or noncommunicable diseases. These conditions often necessitate frequent and long-term administration of medications, including chemotherapy, insulin, and antibiotics, as well as regular blood sampling.

Vascular access devices offer a reliable and less painful alternative to repeated venipunctures, making them essential in the long-term care of such patients. For example, implanted ports or peripherally inserted central catheters (PICCs) greatly aid cancer patients enduring chemotherapy cycles by enabling the safe and repetitive administration of cytotoxic medications. Additionally, the need for effective vascular access in acute and home care settings is only going to increase with rising hospitalization rates and an aging population. As healthcare providers focus more on improving patient comfort and streamlining drug delivery, the adoption of these devices continues to expand globally. For instance, in November 2023, BD (Becton, Dickinson and Company) launched SiteRite 9 Ultrasound System, an advanced ultrasound system designed to deliver enhanced image quality and as a vessel assessment tool to improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.

Antimicrobial-coated catheters: enhancing safety and reducing infection risk

The advent of antimicrobial-coated catheters, has improved the efficacy and safety of vascular access devices. These catheters are embedded or coated with substances such as silver sulfadiazine, chlorhexidine, or minocycline-rifampin that actively prevent bacterial colonization. By minimizing microbial adhesion to catheter surfaces, these coatings help reduce the risk of catheter-related bloodstream infections (CRBSIs), a major concern in long-term vascular access. According to some studies, using such coated devices in clinical settings can result in a measurable drop in infection rates, thereby resulting in decreased patient morbidity and shortened hospital stay. This technique has becoming more and more common in hospitals and infusion facilities, especially for high-risk patients with weak immune systems. Moreover, regulatory approvals and inclusion in infection prevention guidelines by institutions such as the CDC have further accelerated its integration into routine practice. This innovation not only enhances patient safety but also supports cost savings for healthcare providers.

Competitive Landscape Analysis

The global vascular access device market is marked by the presence of established and emerging market players such BD; Teleflex Medical; B. Braun; AngioDynamics; ICU Medical, Inc; Medtronic; Medical Components, Inc.; Cook Medical; Terumo Medical Corporation; Access Vascular, Inc among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Download a sample report for in-depth competitive insights
https://meditechinsights.com/vascular-access-device-market/request-sample/

Global Vascular Access Device Market Segmentation

This report by Medi-Tech Insights provides the size of the global vascular access device market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type and end-user.

Market Size & Forecast (2023-2030), By Type, USD Million

  • Peripheral
  • Central
    • CVCs
    • PICCs
    • Implantable Ports
  • Intraosseous
  • Accessory

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

 

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more